CLINICAL_TRIALS
trial_result
· 2025-12-24
Clinical Trial Update: Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing [NA]
Summary
A completed study evaluating resiliency training delivered to adults with neurofibromatosis via live videoconferencing.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Neurofibromatoses, Neurofibromatosis 1 | NA | Status: COMPLETED